MENU
CRIS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Curis (CRIS) Ownership - Who owns Curis?
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
128 Spring Street
Phone
+1 617 503-6500
Employees
49
Web
https://www.curis.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
22.81M
P/E Ratio
N/A
Total Cash
20.28M
Projected Growth
N/A
Total Debt
2.64M
Revenue
11.2M
Risk (Beta)
3.35
Dividend Yield
N/A
Total Cash/Share
1.94
Total Debt/Equity
74.54
Revenue/Share
1.60 USD as % of share price
Fundamentals
CRIS
Capitalization
22.8M
P/E Ratio
N/A
Risk (Beta)
3.35
Dividend Yield
N/A
Total Cash
20.3M
Total Cash/Share
1.94
Total Debt
2.64M
Total Debt/Equity
74.54
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.60%
Revenue
11.2M
ROE
N/A
Book Value
-6.61M
P/B Ratio
3.41
Cash Flow
N/A
Earnings
-6.08
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
105K
Current Ratio
1.23
Current Revenue Per Employee
72121.21
Dividends Per Share - Security
N/A
EBITDA
-40.26M
Float
N/A
Float - Current
N/A
Gross Income Margin
99.41
Revenue To Assets
-83.14
Shares Held By Institutions
84.9M
Shares Outstanding - Current
10.5M
Total Liabilities
45.9M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-29.085
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a drug company
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
128 Spring Street
Phone
+1 617 503-6500
Employees
49
Web
https://www.curis.com